Yu, Helena A <br/><br/>
Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  10 2017 
 - 195-199 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2017.08.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pulse Therapy, Drug<br/>Quinazolinones--administration & dosage